Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Epigenetics at the base of alternative splicing changes that promote colorectal cancer
Alberto R. Kornblihtt
Alberto R. Kornblihtt
Published August 21, 2017
Citation Information: J Clin Invest. 2017;127(9):3281-3283. https://doi.org/10.1172/JCI96497.
View: Text | PDF
Commentary Article has an altmetric score of 2

Epigenetics at the base of alternative splicing changes that promote colorectal cancer

  • Text
  • PDF
Abstract

Chromatin modification influences gene expression by either repressing or activating genes, depending on the specific histone mark. Chromatin structure can also influence alternative splicing of transcripts; however, the mechanisms by which epigenetic marks influence splicing are poorly understood. A report in the current issue of the JCI highlights the biological importance of the coordinated control of alternative pre-mRNA splicing by chromatin structure and transcriptional elongation. Yuan et al. found that mutation of the histone methyl transferase SEDT2 affects alternative splicing fates of several key regulatory genes, including those involved in Wnt signaling. As a consequence, loss of SEDT2 in the intestine aggravated Wnt/β-catenin signaling effects, thereby leading to colorectal cancer.

Authors

Alberto R. Kornblihtt

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 Total
Citations: 1 2 1 3 1 2 3 1 14
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (14)

Title and authors Publication Year
The potential impact of RNA splicing abnormalities on immune regulation in endometrial cancer
Cao M, Yan J, Ding Y, Zhang Y, Sun Y, Jiang G, Zhang Y, Li B
Cell Death & Disease 2025
PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
Chang Z, Jia Y, Gao M, Song L, Zhang W, Zhao R, Yu D, Liu X, Li J, Qin Y
Biology direct 2024
Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activation
Venkatasubramanian M, Schwartz L, Ramachandra N, Bennett J, Subramanian KR, Chen X, Gordon-Mitchell S, Fromowitz A, Pradhan K, Shechter D, Sahu S, Heiser D, Scherle P, Chetal K, Kulkarni A, Myers KC, Weirauch MT, Grimes HL, Starczynowski DT, Verma A, Salomonis N
2024
SETD2 deficiency promotes renal fibrosis through the TGF‐β/Smad signalling pathway in the absence of VHL
Liu C, Ni L, Li X, Rao H, Feng W, Zhu Y, Zhang W, Ma C, Xu Y, Gui L, Wang Z, Aji R, Xu J, Gao W, Li L
Clinical and Translational Medicine 2023
Alternative Splicing in Cancer and Immune Cells
A Bernard, R Boidot, F Végran
Cancers 2022
Crosstalk between macrophage-derived PGE2 and tumor UHRF1 drives hepatocellular carcinoma progression
Zhang J, Zhang H, Ding X, Hu J, Li Y, Zhang J, Wang H, Qi S, Xie A, Shi J, Xiang M, Bin Y, Wang G, Wang L, Wang Z
Theranostics 2022
Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI
Volovat SR, Augustin I, Zob D, Boboc D, Amurariti F, Volovat C, Stefanescu C, Stolniceanu CR, Ciocoiu M, Dumitras EA, Danciu M, Apostol DG, Drug V, Shurbaji SA, Coca LG, Leon F, Iftene A, Herghelegiu PC
Cancers 2022
Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer
K Kitamura, K Nimura
Cells 2021
Prognostic alternative splicing signature in cervical squamous cell carcinoma
H Wu, Q Li, L Liang, L Qiu, H Wei, B Huang, C Gang-, R He, Z Huang, W Hou, Q Hu, S Pan
IET Systems Biology 2020
The HNRNPA2B1–MST1R–Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer
A Gupta, S Yadav, A PT, J Mishra, A Samaiya, RK Panday, S Shukla
Laboratory Investigation 2020
Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data
HY Wu, ZG Peng, RQ He, B Luo, J Ma, XH Hu, YW Dang, G Chen, SL Pan
International journal of oncology 2019
Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events
HY Wu, Y Wei, LM Liu, ZB Chen, QP Hu, SL Pan
Oncology Letters 2019
Histone Modifications and their Role in Colorectal Cancer (Review)
J Qin, B Wen, Y Liang, W Yu, H Li
Pathology & Oncology Research 2019
Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer
WJ Ma, X Wang, WT Yan, ZG Zhou, ZZ Pan, G Chen, RX Zhang
World journal of gastroenterology : WJG 2018

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 2 X users
On 2 Facebook pages
41 readers on Mendeley
See more details